Psychoactive Medication and Traffic Safety

International Journal of Environmental Research and Public Health

Volumn 6, Issue 3, 2009, Pages 1041-1054

  Verster, Joris C ^a   Mets, Monique A J ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Driving; Drugs; ICADTS; Psychoactive medication; Traffic safety

Indexed keywords

ANALGESIC AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; ANXIOLYTIC AGENT; BROMAZEPAM; BROTIZOLAM; BUSPIRONE; CENTRAL STIMULANT AGENT; CHLORDIAZEPOXIDE; CLOBAZAM; ESTAZOLAM; FLUNITRAZEPAM; FLURAZEPAM; HYPNOTIC SEDATIVE AGENT; LOPRAZOLAM; LORMETAZEPAM; MEDAZEPAM; MIDAZOLAM; NITRAZEPAM; PSYCHOTROPIC AGENT; QUAZEPAM; SECOBARBITAL; SEROTONIN UPTAKE INHIBITOR; TEMAZEPAM; TRIAZOLAM; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; ZALEPLON; ZOLPIDEM; ZOPICLONE;

ALERTNESS; ARTICLE; DRIVING ABILITY; HUMAN; PSYCHOMOTOR DISORDER; TRAFFIC SAFETY; VISUAL IMPAIRMENT;

EID: 67649230779     PISSN: None     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph6031041     Document Type: Article

References (29)

1. Drugs, driving and traffic safety. Verster, Pandi-Perumal, S.R., Ramaekers, J.H.G., De Gier, J.J., Eds.; Birkhauser Verlag: Basel, Switzerland, 2009.
2. Global Pharmaceutical Sales 2000 - 2007; IMS Health Market Prognosis: Norwalk, CT, USA, 2008; http: //www imshealth.com/deplo yedfiles/imshealth/Glob al/Content/S taticFile/Top-Line-Data/GlobalSales.pdf (accessed March 28, 2008).
3. Peden, M.; Scurfield, R.; Sleet, D.; Mohan, D.; Jayder, A.; Jarawan, E.; Mathers, C. World report on road traffic injury prevention. World Health Organization: Geneva, Switzerland, 2004.
4. Verster, J.C. Measurement of the effects of psychoactive drugs on driving ability and related psychological processes. Ph.D. Thesis, University of Utrecht: Utrecht, The Netherlands, October 2002.
5. Moskowitz, H.; Fiorentino, D. Areview of the literature on the effects of low doses of alcohol on driving-related skills. US Department of Transportation, National Highway Traffic Safety Administration: Washington, DC, USA, Report DOT HS 809 028, 2000.
6. Volkerts, E.R.; van Laar, M.W.; van Willigenburg, A.P.P. A comparative study of on-the-road and simulated driving performance after nocturnal treatment with lormetazepam 1 mg and oxazepam 50 mg. Hum. Psychopharmacol. 1992, 7, 297-309.
7. O'Hanlon, J.F.; Haak, T.W.; Blauw, G.J.; Riemersma, J.B.J. Diazepam impairs lateral position control in highway driving. Science 1982, 217, 79-81.
8. Categorization System for Medicinal Drugs Affecting Driving Performance; ICADTS: Oslo, Norway; www.icadts.nl/reports/medicinaldrugsl.pdf (accessed June 26, 2007)
9. Louwerens, J.W.; Gloerich, A.B.M.; De Vries, G. The relationship between drivers' blood alcohol concentration (BAC) and actual driving performance during high speed travel. In Alcohol, Drugs and Traffic Safety, Proceedings of the 10th International Conference on Alcohol, Drugs and Traffic Safety; Amsterdam, The Netherlands, 9-12 September 1986; Noordzij, P.C., Roszbach, R., Eds.; Excerpta Medica: Amsterdam, The Netherlands, 1987; pp. 183-192.
10. Verster, J.C.; Veldhuijzen, D.S.; Volkerts, E.R. Residual effects of sleep medication on driving ability. Sleep Med. Rev. 2004, 8, 309-325.
11. Vermeeren, A. Residual effects of hypnotics: epidemiology and clinical implications. CNS Drugs 2004, 18, 297-328.
12. Verster, J.C.; Veldhuijzen, D.S.; Patat, A.; Olivier, B.; Volkerts, E.R. Hypnotics and driving safety: meta-analyses of randomized controlled trials applying the on-the-road driving test. Current Drug Safety 2006, 1, 63-72.
13. Verster, J.C.; Volkerts, E.R.; Schreuder, A.H.C.M.L.; Eijken, E.J.E.; van Heuckelum, J.H.G.; Veldhuijzen, D.S.; Verbaten, M.N.; Patat, A.; Paty, I. Residual effects of middle-of-the-night administration of zaleplon and Zolpidem on driving ability, memory functions, and psychomotor performance. J. Clin. Psychopharmacol. 2002, 22, 576-583.
14. Verster, J.C.; Volkerts, E.R; Johnson, W.; Liddicoat, L. Zoplidem and traffic safety - the importance of treatment compliance. Cur. Drug Saf. 2007, 2, 220-226.
15. Barbone, F.; McMahon, A.D.; Davey, P.G.; Morris, A.D.; Reid, I.C.; McDevitt, D.G.; MacDonald, T.M. Association of road traffic accidents with benzodiazepine use. The Lancet 1998, 352, 1331-1336.
16. Verster, J.C.; Veldhuijzen, D.S.; Volkerts, E.R. Is it safe to drive a car when treated with anxiolytics? Evidence from on-the-road driving studies during normal traffic. Cur. Psychiat. Rev. 2005, 1, 215-225.
17. Ramaekers, J.G. Antidepressants and driver impairment: empirical evidence from a standard on-the-road test. J. Clin. Psychiat. 2003, 64, 20-29.
18. Verster, J.C.; Volkerts, E.R. Antihistamines and driving ability: Evidence from on-the-road driving studies during normal traffic. Annals Allergy, Asthma Immunol. 2004, 92, 294-303.
19. Veldhuijzen, D.S.; van Wijck, A.J.M.; Verster, J.C.; Kenemans, J.L.; Kalkman, C.J.; Olivier, B.; Volkerts, E.R. Acute and subchronic effects of amitriptyline 25 mg on actual driving in chronic neuropathic pain patients. J. Psychopharmacol. 2006, 20, 782-788.
20. Verster, J.C.; Veldhuijzen, D.S.; Volkerts, E.R. Effects of an opioid (oxycodone / paracetamol) and an NSAID (bromfenac) on driving ability, memory functioning, psychomotor performance, pupil size and mood. Clin. J. Pain 2006, 22, 499-504.
21. Zacny, J.P. Should people taking opioids for medical reasons be allowed to work and drive? Addiction 1996, 91, 1581-1584.
22. Veldhuijzen, D.S.; van Wijck, A.J.M.; Wille, F.; Verster, J.C.; Kenemans, J.L.; Kalkman, C.J.; Olivier, B.; Volkerts, E.R. Effects of chronic nonmalignant pain on highway driving performance. Pain 2006, 122, 28-35.
23. Ramaekers, J.G.; Kuypers, K.P.C.; Samyn, N. Stimulant effects of 3-4- methylendioxymethamphetamine (MDMA) 75 mg and methylphenidate 20 mg on actual driving during intoxication and withdrawal. Addiction 2006, 101, 1614-1621.
24. Verster, J.C.; Bekker, E.M.; de Roos, M.; Minova, A.; Eijken, E.J.E.; Kooij, J.J.S.; Buitelaar, J.K.; Kenemans, J.L.; Verbaten, M.N.; Olivier, B.; Volkerts, E.R. Methylphenidate and driving ability of adults with attention-deficit hyperactivity disorder: a randomized crossover trial. J. Psychopharmacol. 2008, 22, 230-239.
25. Neutel, I. Benzodiazepine-related traffic accidents in young and elderly drivers. Human Psychopharm. Clin. 1998, 13, S115-S123.
26. Van Laar, M.W.; Volkerts, E.R.; van Willigenburg, A.P.P. Therapeutic effects and effects on actual driving performance of chronically administered buspirone and diazepam in anxious outpatients. J. Clin. Psychopharmacol. 1992, 12, 86-95.
27. McGwin, G.; Sims, R.V.; Pulley, L.; Roseman, J.M. Relationship among chronic medical conditions, medications, and automobile crashes in the elderly: a population-based casecontrol study. Am. J. Epidemiol. 2000, 152, 424-431.
28. Vermeeren, A.; Ramaekers, J.G.; O'Hanlon, J.F. Effects of emedastine and cetirizine, alone and with alcohol, on actual driving of males and females. J. Psychopharmacol. 2002, 16, 57-64.
29. Verster, J.C.; Volkerts, E.R.; Spence, W.; Alford, C; Pandi-Perumal, S.R Hypnotics and daytime functioning: effects of sleep medications on cognition, psychomotor skills, and memory functioning in geriatric patients. Current Psychiat. Rev. 2007, 3, 281-292.